Menggang Yu

25PUBLICATIONS
176CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsStochastic analysis and modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Sep 03, 2026
Window-of-Opportunity Study Utilizing Preoperative Cetuximab in Patients with Head and Neck Cancer.

|May 29, 2026
A Quantitative Framework to Assess the Potential of Earlier Cancer Detection to Improve Cancer Survival.

|Apr 19, 2026
Gemcitabine plus Nivolumab with Carboplatin or Oxaliplatin in Cisplatin-Ineligible Patients with Metastatic Urothelial Carcinoma: A Randomized Phase II Trial.

|Mar 06, 2026
OPERA: a new algorithm for patient stratification based on partially ordered risk factors.

Yingzhou Liu, Menggang Yu

|Jan 22, 2026
Confidence Interval Construction for Causally Generalized Estimates With Target Sample Summary Information.

Yi Chen, Guanhua Chen, Menggang Yu

|May 29, 2025
CARM1-Mediated MAP2K4 Methylation Potentiates the Oncogenic Functions of MAP2K4 and Constitutes a Targetable Dependency in Triple-Negative Breast Cancer.

Eui-Jun Kim, Yidan Wang, Yu-Lin Chen

Pageof 5

Frequent Collaborators

4 joint publications

Jared D Huling

3 joint publications

John M Floberg

3 joint publications

Marina Sharifi

3 joint publications

Matthew L Bootsma